[144] Camtek Ltd SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Camtek Ltd (CAMT) reporting a proposed sale of 4,018 ordinary shares through Oppenheimer & Co. Inc. on or about 08/22/2025 with an aggregate market value of $328,431.32. The filing lists the acquisition history for the securities sold: a mix of performance stock units and restricted stock units acquired on 04/28/2021, 01/24/2022 and 01/16/2023, totaling the reported shares. The filer certifies no undisclosed material adverse information. The notice contains no prior sales in the past three months.

Positive

• Transparent disclosure of the broker, approximate sale date, aggregate market value, and acquisition history (PSUs and RSUs).
• Certification that the seller does not possess undisclosed material adverse information and disclosure of no sales in the past three months.

Negative

• Proposed sale of 4,018 shares will increase circulating supply of insider-held shares, which could have a market impact depending on liquidity and context.

Insights

Financial Analyst

TL;DR Routine insider sale notice for a small block of shares; provides acquisition dates and broker details.

The filing documents a proposed sale of 4,018 ordinary shares via Oppenheimer & Co., stating an aggregate market value of $328,431.32 and listing acquisition dates and grant types (PSUs and RSUs). This is a procedural disclosure under Rule 144 that notifies the market of an intended disposition by an insider or person included in Rule 144's definition. The filing does not include earnings, forward guidance, or other operational data.

Corporate Governance Expert

TL;DR Compliance-focused filing showing transparent reporting of share provenance and planned brokered sale.

The notice includes the broker name and address, the approximate sale date, and detailed sourcing of the securities (PSUs and RSUs with specific grant dates). It also contains the required certification regarding material nonpublic information. There are no reported sales in the prior three months, indicating this notice stands alone rather than part of a rapid sequence of disposals.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	4018	328431.32	45449306	08/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	04/28/2021	PSU	From the Issuer			236	04/28/2021	N/A
Ordinary	01/24/2022	PSU	From the Issuer			651	01/24/2022	N/A
Ordinary	01/16/2023	PSU	From the Issuer			657	01/16/2023	N/A
Ordinary	04/28/2021	Restricted Stock Units	From the Issuer			349	04/28/2021	N/A
Ordinary	01/24/2022	Restricted Stock Units	From the Issuer			871	01/24/2022	N/A
Ordinary	01/16/2023	Restricted Stock Units	From the Issuer			1254	01/16/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for CAMT report?

The filing reports a proposed sale of 4,018 ordinary shares through Oppenheimer & Co. with an aggregate market value of $328,431.32, approximate sale date 08/22/2025.

Who is the broker listed on the CAMT Form 144?

The broker named is Oppenheimer & Co. Inc., 85 Broad St. New York NY 10004.

What types of awards were the shares acquired as?

The securities were acquired as performance stock units (PSUs) and restricted stock units (RSUs) on 04/28/2021, 01/24/2022 and 01/16/2023.

Does the filing indicate any sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months.

Does the filer assert possession of any undisclosed material information?

By signing, the person represents they do not know any material adverse information regarding the issuer that has not been publicly disclosed.